INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
(NASDAQ: INMB) Delayed: 2.33 +0.15 (6.88%)
Previous Close $2.18    52 Week High $ 
Open $2.22    52 Week Low $ 
Day High $2.40    P/E N/A 
Day Low $2.21    EPS $ 
Volume 677,642       

(NASDAQ: INMB) Delayed: 2.33 +0.15 (6.88%)
Previous Close $2.18    52 Week High $ 
Open $2.22    52 Week Low $ 
Day High $2.40    P/E N/A 
Day Low $2.21    EPS $ 
Volume 677,642